Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (NQ: EDAP )

2.860 +0.230 (+8.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

< Previous 1 2 3 4 5 Next >
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
From EDAP TMS S.A.
Via GlobeNewswire
Edap TMS's Earnings: A Preview
Via Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
From EDAP TMS S.A.
Via GlobeNewswire
Therapeutic Ultrasound Player EDAP Shares Jump On Street Beating Q2 Earnings
Via Benzinga
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
EDAP Announces Record Q4 US Focal One Placements
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Intuit To $490? Here Are 5 Other Price Target Changes For Friday
Barclays cut Intuit Inc. (NASDAQ: INTU) price target from $502 to $490. . Barclays analyst Raimo Lenschow maintained an Overweight rating on the stock. Intuit shares fell 3% to close at $381.88 on... 
Via Benzinga
EDAP Reports Third Quarter 2022 Results
From EDAP TMS S.A.
Via GlobeNewswire
Earnings Outlook For Edap TMS
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Wednesday, 2022-11-16. Here's what investors need to know before the announcement. Analysts estimate that Edap TMS will... 
Via Benzinga
Earnings Scheduled For November 16, 2022
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is estimated to report earnings for its third quarter. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million. 
Via Benzinga
EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY23
From EDAP TMS S.A.
Via GlobeNewswire
Why EDAP Shares Are Falling Sharply
EDAP TMS SA (NASDAQ: EDAP) shares are trading lower by 14.24% to $7.35 Friday morning after the company priced a roughly 2.66 million ADS public offering at $7.50 per ADS. What Else? 
Via Benzinga
11 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
Gainers HHG Capital Corporation (NASDAQ: HHGC) shares rose 42.1% to $14.56 in pre-market trading. 
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
Costco Wholesale, Credit Suisse And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning after recording losses in the previous session. Here are some big stocks moving lower in today’s pre-market trading session. 
Via Benzinga
FedEx, Costco And 3 Stocks To Watch Heading Into Friday
With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million. 
Via Benzinga
Earnings Scheduled For August 24, 2022
Companies Reporting Before The Bell • CNFinance Hldgs (NYSE:CNF) is estimated to report quarterly earnings at $0.03 per share on revenue of $69.74 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.